| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919550 | Radiotherapy and Oncology | 2013 | 5 Pages |
Abstract
Since the 6-month survival rates in the validation group were very similar to the test group, this new score (WBRT-30) appears valid and reproducible. It can help making treatment choices and stratifying patients in future trials.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Dirk Rades, Liesa Dziggel, Viorica Nagy, Barbara Å egedin, Radka Lohynska, Theo Veninga, Mai T. Khoa, Ngo T. Trang, Steven E. Schild,